CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
9.38
-0.57 (-5.73%)
May 6, 2025, 4:00 PM EDT - Market closed
CervoMed Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CervoMed stock have an average target of 25.43, with a low estimate of 10 and a high estimate of 63. The average target predicts an increase of 171.11% from the current stock price of 9.38.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 26, 2025.
Analyst Ratings
The average analyst rating for CervoMed stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 3 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +6.61% | Mar 26, 2025 |
| Roth MKM | Roth MKM | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | +113.22% | Mar 18, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $21 | Strong Buy | Maintains | $12 → $21 | +123.88% | Mar 18, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $14 | Strong Buy | Maintains | $14 | +49.25% | Mar 18, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +6.61% | Mar 17, 2025 |
Financial Forecast
Revenue This Year
5.69M
from 9.74M
Decreased by -41.60%
Revenue Next Year
n/a
from 5.69M
EPS This Year
-2.08
from -2.02
EPS Next Year
-1.83
from -2.08
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.5M | n/a | n/a | ||
| Avg | 5.7M | n/a | n/a | ||
| Low | 2.3M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 28.1% | - | - | ||
| Avg | -41.6% | - | - | ||
| Low | -76.9% | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.35 | -0.66 | -0.36 | ||
| Avg | -2.08 | -1.83 | -1.55 | ||
| Low | -2.63 | -2.94 | -2.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.